Kang K - Search Results

1

FcIgG receptor-bearing lymphocytes and monoclonal antibody-defined T cell subsets in atopic dermatitis: effect of treatment with thymopoietin pentapeptide (TP-5).

Strannegård O, Strannegård IL, Kang K, Cooper KD, Hanifin JM. Strannegård O, et al. Among authors: kang k. Int Arch Allergy Appl Immunol. 1982;69(3):238-44. doi: 10.1159/000233177. Int Arch Allergy Appl Immunol. 1982. PMID: 6752042 Clinical Trial.

2

Suppressor cell phenotype deficiency and its restoration by thymopoietin pentapeptide in atopic dermatitis.

Kang K, Strannegård O, Strannegård IL, Cooper K, Hanifin JM. Kang K, et al. Monogr Allergy. 1983;18:181-5. Monogr Allergy. 1983. PMID: 6227816 Review. No abstract available.

3

Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis.

Kang K, Cooper KD, Hanifin JM. Kang K, et al. J Am Acad Dermatol. 1983 Mar;8(3):372-7. doi: 10.1016/s0190-9622(83)70042-3. J Am Acad Dermatol. 1983. PMID: 6339571 Clinical Trial.

4

Effects of thymopoietin pentapeptide (TP-5) on in vitro and in vivo IgE production by atopic dermatitis cell subsets.

Cooper KD, Kang K, Hanifin JM. Cooper KD, et al. Among authors: kang k. Diagn Immunol. 1983;1(3):211-5. Diagn Immunol. 1983. PMID: 6388971 Clinical Trial.

5

Phosphodiesterase inhibition by Ro 20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro.

Cooper KD, Kang K, Chan SC, Hanifin JM. Cooper KD, et al. Among authors: kang k. J Invest Dermatol. 1985 Jun;84(6):477-82. doi: 10.1111/1523-1747.ep12272486. J Invest Dermatol. 1985. PMID: 3998494 Free article.

6

Direct depletion and purification of monoclonal antibody defined cells from unfractionated human mononuclear leukocytes using antibody coated polystyrene Petri dishes.

Cooper KD, Kang K, Bush TL, Hanifin JM. Cooper KD, et al. Among authors: kang k. J Clin Lab Immunol. 1984 Feb;13(2):97-100. J Clin Lab Immunol. 1984. PMID: 6610057

7

Atopic dermatitis: introduction and overview.

Stevens SR, Kang K, Cooper KD. Stevens SR, et al. Among authors: kang k. J Cutan Med Surg. 1999 Feb;3 Suppl 2:S2-2-S2-7. doi: 10.1177/12034754990030s202. J Cutan Med Surg. 1999. PMID: 10071359 Review. No abstract available.

8

Immunosuppression in a homosexual man with Kaposi's sarcoma.

Rasmussen EO, Cooper KD, Kang K, White CR Jr, Regan DH, Hanifin JM. Rasmussen EO, et al. Among authors: kang k. J Am Acad Dermatol. 1982 May;6(5):870-9. doi: 10.1016/s0190-9622(82)70076-3. J Am Acad Dermatol. 1982. PMID: 6284810

9

CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein.

Kang K, Hammerberg C, Meunier L, Cooper KD. Kang K, et al. J Immunol. 1994 Dec 1;153(11):5256-64. J Immunol. 1994. PMID: 7963579

10

Differential regulation of IL-1 and IL-1 receptor antagonist in HaCaT keratinocytes by tumor necrosis factor-alpha and transforming growth factor-beta 1.

Kang K, Hammerberg C, Cooper KD. Kang K, et al. Exp Dermatol. 1996 Aug;5(4):218-26. doi: 10.1111/j.1600-0625.1996.tb00120.x. Exp Dermatol. 1996. PMID: 8889469 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,821 results

Search Page